Disclosure of clinically actionable genetic variants to thoracic aortic dissection biobank participants

BACKGROUND: Disclosure of pathogenic variants to thoracic aortic dissection biobank participants was implemented. The impact and costs, including confirmatory genetic testing in a Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory, were evaluated. METHODS: We exome sequenced 240...

Descripción completa

Detalles Bibliográficos
Autores principales: Beil, Adelyn, Hornsby, Whitney, Uhlmann, Wendy R., Aatre, Rajani, Arscott, Patricia, Wolford, Brooke, Eagle, Kim A., Yang, Bo, McNamara, Jennifer, Willer, Cristen, Roberts, J. Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923508/
https://www.ncbi.nlm.nih.gov/pubmed/33648514
http://dx.doi.org/10.1186/s12920-021-00902-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923508/
https://www.ncbi.nlm.nih.gov/pubmed/33648514
http://dx.doi.org/10.1186/s12920-021-00902-5

Ejemplares similares